Share of Clicks for top 10 US Pharma & Biotech Research and Development brands
Here are the Top 10 competitors in the industry by Share of Clicks for the last month.
| Domain | Share of clicks |
|---|---|
| lilly.com | 7.47 |
| pfizerforall.com | 5.09 |
| merck.com | 2.25 |
| propharmagroup.com | 2.08 |
| evenity.com | 2.04 |
| abbvie.com | 2 |
| ro.co | 1.95 |
| nurtec.com | 1.83 |
| myriad.com | 1.81 |
| tecvayli.com | 1.38 |
| others | 72.1 |
- lilly.com - 7.47%
- pfizerforall.com - 5.09%
- merck.com - 2.25%
- propharmagroup.com - 2.08%
- evenity.com - 2.04%
- abbvie.com - 2%
- ro.co - 1.95%
- nurtec.com - 1.83%
- myriad.com - 1.81%
- tecvayli.com - 1.38%
- others - 72.1%
Copyright © Adthena. All rights reserved.
In the PPC landscape, ‘lilly.com’ leads with 7.47% click share, followed by ‘pfizerforall.com’ at 5.09%. ‘Others’ dominate with 72.1%, highlighting diverse competition.
Share of Spend for the top 10 US Pharma & Biotech Research and Development brands
Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.
| Date | lilly.com | pfizerforall.com | evenity.com | myriad.com | nurtec.com | tepezza.com | ro.co | propharmagroup.com | merck.com | abbvie.com |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025/10/01 | 6.25% | 2.09% | 2.98% | 0.34% | 1.73% | 3.16% | 2.1% | 5.03% | 0.92% | 0.77% |
| 2025/10/02 | 4.15% | 3.88% | 5.16% | 0.99% | 1.33% | 4% | 1.44% | 4.5% | 1.35% | 1.62% |
| 2025/10/03 | 5.18% | 3.39% | 8.14% | 1.8% | 1.22% | 3.6% | 4.46% | 1.28% | 0.65% | 1.21% |
| 2025/10/04 | 5.57% | 3.35% | 14.84% | 1.46% | 1.2% | 1.92% | 2.74% | 1.13% | 0.2% | 2.96% |
| 2025/10/05 | 5.55% | 6.36% | 9.86% | 1.15% | 1.34% | 2.8% | 1.19% | 2.15% | 1.09% | 3.37% |
| 2025/10/06 | 3.79% | 6.19% | 5.99% | 0.68% | 1.25% | 2.98% | 1.83% | 1.86% | 2.26% | 1.54% |
| 2025/10/07 | 4.87% | 4.91% | 5.08% | 1.73% | 1.17% | 2.74% | 1.21% | 2.33% | 2.77% | 2.7% |
| 2025/10/08 | 5.25% | 5.09% | 6.96% | 1.51% | 1.38% | 2.83% | 1.95% | 0.92% | 2.91% | 0.57% |
| 2025/10/09 | 5.57% | 3.53% | 5.59% | 1.71% | 1.2% | 3.38% | 1.34% | 1.25% | 2.29% | 1.67% |
| 2025/10/10 | 7.53% | 4.38% | 4.13% | 2.64% | 1.25% | 2.35% | 0.86% | 2.38% | 0.76% | 1.99% |
| 2025/10/11 | 6.61% | 6.06% | 3.54% | 1.65% | 1.64% | 1.9% | 2.36% | 0.38% | 1.95% | 3.92% |
| 2025/10/12 | 5.07% | 3.63% | 9.79% | 1.1% | 1.47% | 3.35% | 1% | 1.95% | 1.83% | 1.54% |
| 2025/10/13 | 5.1% | 3.86% | 14.13% | 1.45% | 1.41% | 5.15% | 1.44% | 0.74% | 3.06% | 0.44% |
| 2025/10/14 | 4.26% | 4.3% | 10.01% | 1.87% | 1.8% | 4.41% | 1.27% | 0.61% | 0.82% | 2.46% |
| 2025/10/15 | 6.03% | 6.45% | 5.82% | 1.12% | 1.45% | 3.09% | 2.07% | 1.08% | 2.38% | 3.92% |
| 2025/10/16 | 4.43% | 4% | 4.26% | 2.43% | 1.7% | 3.04% | 1.79% | 1.31% | 4.03% | 0.66% |
| 2025/10/17 | 4.11% | 5.12% | 4.73% | 0.8% | 1.95% | 2.36% | 1.42% | 0.78% | 2.68% | 0.89% |
| 2025/10/18 | 11.85% | 4.13% | 5.14% | 1.75% | 1.63% | 2.17% | 2.67% | 0.3% | 2.14% | 2.07% |
| 2025/10/19 | 5.78% | 6.09% | 9.35% | 2% | 2.22% | 1.96% | 2.64% | 2.67% | 1.93% | 0% |
| 2025/10/20 | 4.12% | 5.33% | 3.48% | 0.89% | 2.11% | 2.25% | 1.49% | 4.1% | 1.83% | 5.1% |
| 2025/10/21 | 5.53% | 8.38% | 6.1% | 1.5% | 1.42% | 2.27% | 1.48% | 2.48% | 2.42% | 2.14% |
| 2025/10/22 | 4.8% | 8.07% | 6.24% | 1.31% | 2.34% | 2.83% | 1.62% | 2.16% | 2.52% | 0.05% |
| 2025/10/23 | 6.32% | 5% | 5.41% | 1.39% | 2.3% | 3.12% | 1.3% | 4.04% | 2.72% | 0.93% |
| 2025/10/24 | 7.28% | 10.17% | 2.91% | 0.95% | 1.8% | 2.05% | 1.83% | 5.26% | 0.45% | 2.16% |
| 2025/10/25 | 6.84% | 10.07% | 2.16% | 0.92% | 1.69% | 2.22% | 1.44% | 0.27% | 2.26% | 6.48% |
| 2025/10/26 | 9.33% | 4.52% | 2.65% | 1.73% | 1.59% | 2.28% | 1.28% | 6.02% | 1.07% | 7.15% |
| 2025/10/27 | 4.83% | 6.39% | 1.96% | 1.79% | 1.57% | 2.31% | 1.08% | 4.69% | 1.67% | 0.12% |
| 2025/10/28 | 8.18% | 4.07% | 6.78% | 1.97% | 2.09% | 2.31% | 2.05% | 0.68% | 3.15% | 0.07% |
| 2025/10/29 | 9.57% | 5.67% | 2.05% | 2.27% | 1.76% | 2.07% | 1.64% | 0.72% | 2.61% | 1.17% |
| 2025/10/30 | 11.9% | 4.42% | 3.24% | 2.7% | 1.65% | 2.33% | 1.32% | 1.42% | 0.56% | 4.15% |
| 2025/10/31 | 12.02% | 7.27% | 3.25% | 2.25% | 1.97% | 1.84% | 1.63% | 0.93% | 0.44% | 0% |
- lilly.com
- pfizerforall.com
- evenity.com
- myriad.com
- nurtec.com
- tepezza.com
- ro.co
- propharmagroup.com
- merck.com
- abbvie.com
Copyright © Adthena. All rights reserved.
Lilly.com surged in October, peaking at 12.02% on the 31st. Pfizerforall.com fluctuated, ending at 7.27%. Evenity.com started strong, then dipped. Abbvie.com and myriad.com showed modest gains. Tepezza.com and ro.co remained steady. Propharmagroup.com and merck.com had varied trends.
Competitor Count for US Pharma & Biotech Research and Development
Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.
| Date | Competitor Count |
|---|---|
| 2025/10/01 | 491 |
| 2025/10/02 | 480 |
| 2025/10/03 | 487 |
| 2025/10/04 | 461 |
| 2025/10/05 | 481 |
| 2025/10/06 | 500 |
| 2025/10/07 | 495 |
| 2025/10/08 | 505 |
| 2025/10/09 | 499 |
| 2025/10/10 | 496 |
| 2025/10/11 | 502 |
| 2025/10/12 | 499 |
| 2025/10/13 | 504 |
| 2025/10/14 | 498 |
| 2025/10/15 | 501 |
| 2025/10/16 | 500 |
| 2025/10/17 | 492 |
| 2025/10/18 | 484 |
| 2025/10/19 | 480 |
| 2025/10/20 | 498 |
| 2025/10/21 | 442 |
| 2025/10/22 | 478 |
| 2025/10/23 | 479 |
| 2025/10/24 | 484 |
| 2025/10/25 | 461 |
| 2025/10/26 | 470 |
| 2025/10/27 | 496 |
| 2025/10/28 | 482 |
| 2025/10/29 | 486 |
| 2025/10/30 | 475 |
| 2025/10/31 | 469 |
Copyright © Adthena. All rights reserved.
Advertisers fluctuated throughout October, peaking at 505 on the 8th. A notable dip occurred on the 21st, reaching 442. The month concluded with 469 advertisers.
